Antioxidant strategies in respiratory medicine

Treatments in Respiratory Medicine

Volumn 5, Issue 1, 2006, Pages 47-78

  Christofidou Solomidou, Melpo ^a   Muzykantov, Vladimir R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; [5,10,15,20 TETRAKIS(4 CARBOXYPHENYL)PORPHYRINATO]MANGANESE; AEOL 10113; AEOL 10150; ALPHA CAROTENE; ALPHA TOCOPHEROL; AMIFOSTINE; ANTIOXIDANT; ASCORBIC ACID; BLEOMYCIN; CAROTENOID; CATALASE; COPPER; CURCUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLAVONOID; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOTHIOCYANIC ACID DERIVATIVE; LIPOSOME; M 40401; MACROGOL; MANGANESE; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); MANGANESE SALEN CHLORIDE; MELATONIN; PENTOXIFYLLINE; PHENOL DERIVATIVE; RECOMBINANT SUPEROXIDE DISMUTASE; RETINOL; SELENIUM; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; CANCER; CHRONIC LUNG DISEASE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HUMAN; HYPEROXIA; INFECTION; ISCHEMIA; LEUKOCYTE; LIPID OXIDATION; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; LUNG ENDOTHELIUM; LUNG FIBROSIS; LUNG INJURY; LUNG TOXICITY; MACROPHAGE ACTIVATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; RADIATION INJURY; REPERFUSION; RESPIRATORY DISTRESS; REVIEW; SEPSIS; VITAMIN SUPPLEMENTATION; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; DRUG EFFECTS; METABOLISM; PULMONOLOGY; RESPIRATORY SYSTEM;

ANIMALS; ANTIOXIDANTS; CATALASE; HUMANS; LUNG INJURY; OXIDATIVE STRESS; PULMONARY MEDICINE; REACTIVE OXYGEN SPECIES; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY SYSTEM; SUPEROXIDE DISMUTASE;

EID: 30944445982     PISSN: 11763450     EISSN: 11763450     Source Type: Journal    
DOI: 10.2165/00151829-200605010-00004     Document Type: Review

References (476)

1. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989; 140: 531-4
2. Merker MP, Pitt BR, Choi AM, et al. Lung redox homeostasis: emerging concepts. Am J Physiol Lung Cell Mol Physiol 2000; 279 (3): L413-7
3. Sanders KA, Huecksteadt T, Xu P, et al. Regulation of oxidant production in acute lung injury. Chest 1999; 116 (1 Suppl.): 56S-61S
4. Varani J, Ward P. Mechanisms of endothelial cell injury in acute inflammation. Stroke 1994; 2: 311-9
5. Freeman B, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1987; 47: 412-26
6. Halliwell B. Oxidants and human disease: some new concepts. FASEB J 1987; 1 (5): 358-64
7. Hassoun PM, Yu FS, Cote CG, et al. Upregulation of xanthine oxidase by lipopolysaccharide, interleukin-1, and hypoxia: role in acute lung injury. Am J Respir Crit Care Med 1998; 158 (1): 299-305
8. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: part I. Basic mechanisms and in vivo monitoring of ROS. Circulation 2003; 108 (16): 1912-6
9. Al-Mehdi A, Zhao G, Dodia C, et al. Endothelial NADPH oxidase as the source of oxidants with lung ischemia or high K+. Circ Res 1998; 83: 730-7
10. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64: 97-112
11. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am J Physiol Cell Physiol 1996; 271: C1424-37
12. Vanhoutte PM. Endothelium-derived free radicals: for worse and for better. J Clin Invest 2001; 107 (1): 23-5
13. Cerwinka WH, Cooper D, Krieglstein CF, et al. Nitric oxide modulates endotoxin-induced platelet-endothelial cell adhesion in intestinal venule. Am J Physiol Heart Circ Physiol 2002; 282 (3): H1111-7
14. Kunduzova OR, Bianchi P, Parini A, et al. Hydrogen peroxide production by monoamine oxidase during ischemia/reperfusion. Eur J Pharmacol 2002; 448 (2-3): 225-30
15. Halliwell B, Gutteridge JM. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1984; I (8391): 1396-7
16. Stadtman ER. Protein oxidation and aging. Science 1992; 257 (5074): 1220-4
17. Lee SH, Blair IA. Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc Med 2001; 11 (3-4): 148-55
18. Schroedl C, McClintock DS, Budinger GR, et al. Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 2002; 283 (5): L922-31
19. Waypa GB, Marks JD, Mack MM, et al. Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res 2002; 91 (8): 719-26
20. Walford GA, Moussignac RL, Scribner AW, et al. Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways. J Biol Chem 2004; 279 (6): 4425-32
21. Bertrand Y. Oxygen-free radicals and lipid peroxidation in adult respiratory distress syndrome. Intensive Care Med 1985; 11 (2): 56-60
22. Fessel JP, Porter NA, Moore KP, et al. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc Natl Acad Sci U S A 2002; 99 (26): 16713-8
23. Pratico D, Lawson JA, Rokach J, et al. The isoprostanes in biology and medicine. Trends Endocrinol Metab 2001; 12 (6): 243-7
24. Bowler RP, Crapo JD. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 2002; 110 (3): 349-56
25. Carden D, Young JA, Granger DN. Pulmonary microvascular injury after intestinal ischemia/reperfusion: role of P-selectin. J Appl Physiol 1993; 75: 2529-34
26. Cooper D, Stokes KY, Tailor A, et al. Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation. Cardiovasc Toxicol 2002; 2 (3): 165-80
27. Mulligan M, Vaporciyan A, Warner RL, et al. Compartmentalized roles for leukocytic adhesion molecules in lung inflammation injury. J Immunol 1995; 154: 1350-63
28. Ward PA, Hunninghake GW. Lung inflammation and fibrosis. Am J Respir Crit Care Med 1998; 157: S123-9
29. Lu YT, Chen PG, Liu SF. Time course of lung ischemia-reperfusion-induced ICAM-1 expression and its role in ischemia-reperfusion lung injury. J Appl Physiol 2002; 93 (2): 620-8
30. Azuma A, Takahashi S, Nose M, et al. Role of E-selectin in bleomycin induced lung fibrosis in mice. Thorax 2000; 55 (2): 147-52
31. Bowler RP, Crapo JD. Oxidative stress in airways: is there a role for extracellular superoxide dismutase? Am J Respir Crit Care Med 2002; 166 (12 Pt 2): S38-43
32. Smith KR, Uyeminami DL, Kodavanti UP, et al. Inhibition of tobacco smokeinduced lung inflammation by a catalytic antioxidant. Free Radic Biol Med 2002; 33 (8): 1106-14
33. Davis I, Matalon S. Reactive species in viral pneumonitis: lessons from animal models. News Physiol Sci 2001; 16: 185-90
34. Heunks LM, Vina J, van Herwaarden CL, et al. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999; 277 (6 Pt 2): R1697-704
35. Rahman I. Oxidative stress and gene transcription in asthma and chronic obstruc-tive pulmonary disease: antioxidant therapeutic targets. Curr Drug Targets Inflamm Allergy 2002; 1 (3): 291-315
36. Langen RC, Korn SH, Wouters EF. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 2003; 35 (3): 226-35
37. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 341-57
38. Andreadis AA, Hazen SL, Comhair SA, et al. Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003; 35 (3): 213-25
39. Cerwinka WH, Cooper D, Krieglstein CF, et al. Superoxide mediates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol 2003; 284 (2): H535-41
40. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190 (3): 255-66
41. Bowler RP, Arcaroli J, Abraham E, et al. Evidence for extracellular superoxide dismutase as a mediator of hemorrhage-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2003; 284 (4): L680-7
42. Shenkar R, Abraham E. Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 1999; 163 (2): 954-62
43. Louie S, Halliwell B, Cross C. Adult respiratory distress syndrome: a radical perspective. Adv Pharmacol 1997; 38: 457-90
44. Gao C, Sun W, Christofidou-Solomidou M, et al. Anoikis extended: PECAM-1 inhibits mitochondrial-dependent apoptosis. Blood 2003; 102 (1): 169-79
45. Patel RP, McAndrew J, Sellak H, et al. Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1999; 1411 (2-3): 385-400
46. Tsuji C, Shioya S, Hirota Y, et al. Increased production of nitrotyrosine in lung tissue of rats with radiation-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000; 278 (4): L719-25
47. Nozue M, Ogata T. Correlation among lung damage after radiation, amount of lipid peroxides, and anti-oxidant enzyme activities. Exp Mol Pathol 1989; 50: 239-52
48. Keane T, Van Dyk J, Rider W. Idiopathic interstitial pneumonia following bone marrow transplantation. Int J Radiat Oncol Biol Phys 1981; 7: 1365-70
49. Fryer C, Fitzpatrick P, Rider W, et al. Radiation pneumonitis: experience following a large single dose of radiation. Int J Radiat Oncol Biol Phys 1978; 4: 931-6
50. Robnett TJ, Machtay M, Vines EF, et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000; 48 (1): 89-94
51. Mousas B, Raffin TA, Epstein AH, et al. Pulmonary radiation injury. Chest 1997; 111: 1061-76
52. Kwok E, Chan CK. Corticosteroids and azathioprine do not prevent radiation-induced lung injury. Can Respir J 1998; 5 (3): 211-4
53. Ward HE, Kemsley L, Davies L, et al. The effect of steroids on radiation-induced lung disease in the rat. Radiat Res 1993; 136 (1): 22-8
54. Inoue A, Kunitoh H, Sekine I, et al. Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 2001; 49 (3): 649-55
55. Steiner DR, Gonzalez NC, Wood JG. Interaction between reactive oxygen species and nitric oxide in the microvascular response to systemic hypoxia. J Appl Physiol 2002; 93 (4): 1411-8
56. Crapo JD, Barry BE, Foscue HA, et al. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 1980; 115: 123-43
57. Turrens JF, Freeman BA, Crapo JD. Hyperoxia increases H2O2 release by lung mitochondria and microsomes. Arch Biochem Biophys 1982; 216: 411-21
58. Lightfoot RT, Khov S, Ischiropoulos H. Transient injury to rat lung mitochondrial DNA after exposure to hyperoxia and inhaled nitric oxide. Am J Physiol Lung Cell Mol Physiol 2004; 286 (1): L23-9
59. Chang LY, Subramaniam M, Yoder BA, et al. A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2003; 167 (1): 57-64
60. Contreras M, Hariharan N, Lewandoski JR, et al. Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Crit Care Med 1996; 24 (1): 29-37
61. Davis JM. Role of oxidant injury in the pathogenesis of neonatal lung disease. Acta Paediatr Suppl 2002; 91 (437): 23-5
62. Li C, Wright MM, Jackson RM. Reactive species mediated injury of human lung epithelial cells after hypoxia-reoxygenation. Exp Lung Res 2002; 28 (5): 373-89
63. 2. Am J Physiol Lung Cell Mol Physiol 2000; 279 (4): L683-90
64. Wei Z, Costa K, Al-Mehdi AB, et al. Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ Res 1999; 85 (8): 682-9
65. Kozower BD, Christofidou-Solomidou M, Sweitzer TD, et al. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol 2003; 21: 392-8
66. Smith LL. The response of the lung to foreign compounds that produce free radicals. Annu Rev Physiol 1986; 48: 681-192
67. Hay J, Shahzeidi S, Laurent G. Mechanisms of bleomycin-induced lung damage. Arch Toxicol 1991; 65 (2): 81-94
68. Suntres ZE, Shek PN. The pulmonary uptake of intravenously administered liposomal alpha-tocopherol is augmented in acute lung injury. J Drug Target 1996; 4 (3): 151-9
69. Slosman DO, Costabella PM, Roth M, et al. Bleomycin primes monocytes macrophages for superoxide production. Eur Respir J 1990; 3 (7): 772-8
70. Moseley PL, Hemken C, Hunninghake GW. Augmentation of fibroblast proliferation by bleomycin. J Clin Invest 1986; 78 (5): 1150-4
71. Houston M, Estevez A, Chumley P, et al. Binding of xanthine oxidase to vascular endothelium: kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem 1999; 274 (8): 4985-94
72. Tan S, McAdams M, Royall J, et al. Endothelial injury from a circulating mediator following rat liver ischemia. Free Radic Biol Med 1998; 24 (3): 427-34
73. Zweier JL, Kuppusamy P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci U S A 1988; 85: 4046-50
74. Matsubara T, Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 1986; 137: 3295-8
75. 2 released from vascular endothelial cells. Free Radic Biol Med 1993; 14: 217-23
76. Pritchard Jr KA, Groszek L, Smalley DM, et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995; 77: 510-8
77. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992; 339 (8791): 466-9
78. Siflingerbirnboim A, Malik AB. Neutrophil adhesion to endothelial cells impairs the effects of catalase and glutathione in preventing endothelial injury. J Cell Physiol 1993; 155: 234-9
79. Varani J, Fligiel SE, Till GO, et al. Pulmonary endothelial cell killing by human neutrophils: possible involvement of hydroxyl radical. Lab Invest 1985; 53 (6): 656-63
80. Kostikas K, Papatheodorou G, Psathakis K, et al. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003; 124 (4): 1373-80
81. Mathru M, Rooney MW, Dries DJ, et al. Urine hydrogen peroxide during adult respiratory distress syndrome in patients with and without sepsis. Chest 1994; 105 (1): 232-6
82. Britigan BE, Roeder TL, Shasby DM. Insight into the nature and site of oxygen-centered free radical generation by endothelial cell monolayers using a novel spin trapping technique. Blood 1992; 79 (3): 699-707
83. Utsumi H, Yamada K. In vivo electron spin resonance-computed tomography/nitroxyl probe technique for non-invasive analysis of oxidative injuries. Arch Biochem Biophys 2003; 416 (1): 1-8
84. Matot I, Manevich Y, Al-Mehdi AB, et al. Fluorescence imaging of lipid peroxidation in isolated rat lungs during nonhypoxic lung ischemia. Free Radic Biol Med 2003; 34 (6): 785-90
85. Bunnell E, Pacht ER. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148 (5): 1174-8
86. Pittet JF, Mackersie RC, Martin TR, et al. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997; 155 (4): 1187-205
87. Oe T, Arora JS, Lee SH, et al. A novel lipid hydroperoxide-derived cyclic covalent modification to histone H4. J Biol Chem 2003; 278 (43): 42098-105
88. Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990; 15 (4): 129-35
89. Takeda K, Shimada Y, Amano M, et al. Plasma lipid peroxides and alpha-tocopherol in critically ill patients. Crit Care Med 1984; 12 (11): 957-9
90. Quinlan GJ, Lamb NJ, Evans TW, et al. Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit Care Med 1996; 24 (2): 241-6
91. Lee SH, Blair IA. Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem Res Toxicol 2000; 13 (8): 698-702
92. Christofidou-Solomidou M, Kennel S, Scherpereel A, et al. A murine model of acute lung injury induced by Thrombomodulin-directed immunotargeting of a hydrogen peroxide-generating enzyme to pulmonary endothelium. Am J Pathol 2002; 160 (3): 1155-69
93. Morrow JD, Roberts LJ. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 2002; 166 (12 Pt 2): S25-30
94. Quinlan GJ, Evans TW, Gutteridge JM. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Radic Res 1994; 20 (5): 289-98
95. Greenacre SA, Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 2001; 278 (5): L961-7
96. Brennan ML, Wu W, Fu X, et al. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002; 277 (20): 17415-27
97. Gole MD, Souza JM, Choi I, et al. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2000; 278 (5): L961-7
98. Zhu S, Ware LB, Geiser T, et al. Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001; 163 (1): 166-72
99. Beckman KB, Ames BN. Endogenous oxidative damage of mtDNA. Mutat Res 1999; 424 (1-2): 51-8
100. Poulsen HE, Jensen BR, Weimann A, et al. Antioxidants, DNA damage and gene expression. Free Radic Res 2000; 33 Suppl.: S33-9
101. Risom L, Dybdahl M, Bornholdt J, et al. Oxidative DNA damage and defence gene expression in the mouse lung after short-term exposure to diesel exhaust particles by inhalation. Carcinogenesis 2003; 24 (11): 1847-52
102. Shin SJ. Vitamin E Modulates radiation-induced oxidative damage in mice fed a high-lipid diet. J Biochem Mol Biol 2003; 36 (2): 190-5
103. McCord JM. Superoxide dismutase in aging and disease: an overview. Methods Enzymol 2002; 349: 331-41
104. Strolin Benedetti M, Baltes E. Drug metabolism and disposition in children. Fundam Clin Pharmacol 2003; 17 (3): 281-99
105. Sheehan D, Meade G, Foley VM, et al. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 2001; 360 (Pt 1): 1-16
106. Yang Y, Cheng JZ, Singhal SS, et al. Role of glutathione S-transferases in protection against lipid peroxidation: overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation. J Biol Chem 2001; 276 (22): 19220-30
107. Kemper RA, Myers SR, Hurst HE. Detoxification of vinyl carbamate epoxide by glutathione: evidence for participation of glutathione S-transferases in metabo-lism of ethyl carbamate. Toxicol Appl Pharmacol 1995; 135 (1): 110-8
108. Baez S, Segura-Aguilar J, Widersten M, et al. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 1997; 324 (Pt 1): 25-8
109. Rushmore TH, Morton MR, Pickett CB. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991; 266 (18): 11632-9
110. Otterbein LE, Choi AMK. The saga of leucine zippers continues: in response to oxidative stress. Am J Respir Cell Mol Biol 2002; 26: 161-2
111. Xie T, Belinsky M, Xu Y, et al. ARE- and TRE-mediated regulation of gene expression: response to xenobiotics and antioxidants. J Biol Chem 1995; 270: 6894-900
112. Itoh K, Chiba T, Takahashi S, et al. A Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997; 236: 313-22
113. Venugopal R, Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 1998; 17: 3145-56
114. Cho H-Y, Jedlicka AE, Reddy SPM, et al. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 2002; 26 (2): 175-82
115. Cho H-Y, Jedlicka AE, Reddy SPM, et al. Linkage analysis of susceptibility to hyperoxia: Nrf2 is a candidate gene. Am J Respir Cell Mol Biol 2002; 26 (1): 42-51
116. Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci U S A 1999; 96 (22): 12731-6
117. Ortolani O, Conti A, De Gaudio AR, et al. Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome. Shock 2000; 13 (1): 14-8
118. Bouhafs RK, Jarstrand C. Effects of antioxidants on surfactant peroxidation by stimulated human polymorphonuclear leukocytes. Free Radic Res 2002; 36 (7): 727-34
119. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 1988; 85: 9748-52
120. Wood LG, Fitzgerald DA, Lee AK, et al. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr 2003; 77 (10): 150-9
121. Jacobson JM, Michael JR, Hafri MHJ, et al. Antioxidants and antioxidant enzymes protect against pulmonary oxygen toxicity in the rabbit. J Appl Physiol 1990; 68 (3): 1252-9
122. Kandaswami C, Middleton Jr E. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 1994; 366: 351-76
123. Shaheen SO, Sterne JA, Thompson RL, et al. Dietary antioxidants and asthma in adults: population-based case-control study. Am J Respir Crit Care Med 2001; 164 (10 Pt 1): 1823-8
124. Haddad JJ. Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium. Cytokines Cell Mol Ther 2000; 6 (4): 177-87
125. Rahman Q, Abidi P, Afaq F, et al. Glutathione redox system in oxidative lung injury. Crit Rev Toxicol 1999; 29 (6): 543-68
126. Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998; 92 (4): 609-23
127. Kolleck I, Sinha P, Rustow B. Vitamin E as an antioxidant of the lung: mechanisms of vitamin E delivery to alveolar type II cells. Am J Respir Crit Care Med 2002; 166 (12 Pt 2): S62-6
128. Devaraj S, Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation. Circulation 2000; 102 (2): 191-6
129. Faruqi R, De la Motte C, DiCorleto PE. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994; 94 (2): 592-600
130. Princen HM, Van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 1995; 15 (3): 325-33
131. Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 2000; 23: 733-8
132. Kleinveld HA, Hak-Lemmers HL, Hectors MP, et al. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 1995; 15 (2): 290-7
133. Handelman GJ. The evolving role of carotenoids in human biochemistry. Nutrition 2001; 17 (10): 818-22
134. Olson JA. Carotenoids and human health. Arch Latinoam Nutr 1999; 49 (3 Suppl. 1): 7S-11S
135. Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr 2003; 133 Suppl. 3: 933S-40S
136. Ikeda R, Uehara M, Takasaki M, et al. Dose-responsive alteration in hepatic lipid peroxidation and retinol metabolism with increasing dietary beta-carotene in iron deficient rats. Int J Vitam Nutr Res 2002; 72 (5): 321-8
137. Paolini M, Cantelli-Forti G, Perocco P, et al. Co-carcinogenic effect of beta carotene. Nature 1999; 398: 760-1
138. Paolini M, Abdel-Rahman SZ, Sapone A, et al. Beta-carotene: a cancer chemopreventive agent or a co-carcinogen? Mutat Res 2003; 543 (3): 195-200
139. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Oxford University Press, 1999
140. Chen K, Suh J, Carr AC, et al. Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload. Am J Physiol Endocrinol Metab 2000; 279: E1406-12
141. Sardi B, Koobs DH, Bar-Or D, et al. The two faces of vitamin C. Science 2001; 293: 1993-5
142. Lee SH, Oe T, Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2003; 292: 2083-6
143. Tan DX, Chen LD, Poeggeler B, et al. Evaluation of the antioxidant activity of melatonin in vitro. Endocr J 1993; 1: 57-60
144. Mahal HS, Sharma HS, Mukherjee T. Antioxidant properties of melatonin: a pulse radiolysis study. Free Radic Biol Med 1999; 26: 557-65
145. Tan DX, Manchester LC, Reiter RJ, et al. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med 2000; 29: 1177-85
146. Zang LY, Cosma G, Gardner H, et al. Scavenging of reactive oxygen species by melatonin. Biochim Biophys Acta 1998; 1425: 467-77
147. Allegra M, Reiter RJ, Tan DX, et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34 (1): 1-10
148. Fowler G, Daroszewska M, Ingold KU. Melatonin does not 'directly scavenge hydrogen peroxide': demise of another myth. Free Radic Biol Med 2003; 34 (1): 77-83
149. Horstman JA, Wrona MZ, Dryhurst G. Further insights into the reaction of melatonin with hydroxyl radical. Bioorg Chem 2002; 30 (5): 371-82
150. Rapozzi V, Comelli M, Mavelli I, et al. Melatonin and oxidative damage in mice liver induced by the prooxidant antitumor drug, adriamycin. In Vivo 1999; 13 (1): 45-50
151. Arslan SO, Zerin M, Vural H, et al. The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats. J Pineal Res 2002; 32 (1): 21-5
152. Brown KM, Arthur JR. Selenium, selenoproteins and human health: a review. Public Health Nutr 2001; 4 (2B): 593-9
153. Kyriakopoulos A, Behne D. Selenium-containing proteins in mammals and other forms of life. Rev Physiol Biochem Pharmacol 2002; 145: 1-46
154. Hill KE, Motley AK, Li X, et al. Combined selenium and vitamin E deficiency causes fatal myopathy in guinea pigs. J Nutr 2001; 131 (6): 1798-802
155. Hill KE, Zhou J, McMahan WJ, et al. Deletion of selenoprotein P alters distribution of selenium in the mouse. J Biol Chem 2003; 278 (16): 13640-6
156. Burk RF, Hill KE, Boeglin ME, et al. Selenoprotein P associates with endothelial cells in rat tissues. Histochem Cell Biol 1997; 108: 11-5
157. Burk RF, Hill KE, Motley AK. Plasma selenium in specific and non-specific forms. Biofactors 2001; 14: 107-14
158. Burk RF, Hill KE, Motley AK. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 2003; 133 (5 Suppl. 1): 1517S-20S
159. Esposito LA, Kokoszka JE, Waymire KG, et al. Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Radic Biol Med 2000; 28 (5): 754-66
160. Hoekstra WG. Biochemical function of selenium and its relation to vitamin E. Fed Proc 1975; 34 (11): 2083-9
161. Karlsson K, Marklund SL. Plasma clearance of human extracellular- superoxide dismutase C in rabbits. J Clin Invest 1988; 82: 762-6
162. Traber DL, Adams Jr T, Sziebert L, et al. Potentiation of lung vascular response to endotoxin by superoxide dismutase. J Appl Physiol 1985; 58: 1005-9
163. Nelson SK, Bose SK, McCord JM. The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radic Biol Med 1994; 16: 195-200
164. Huang YCT, Nozik ES, Piantadosi CA. Superoxide dismutase potentiates platelet-activating factor-induced injury in perfused lung. Am J Physiol Lung Cell Mol Physiol 1994; 266: L246-54
165. Marklund SL. Properties of extracellular superoxide dismutase from human lung. Biochem J 1984; 220 (1): 269-72
166. Marklund SL. Clinical aspects of superoxide dismutase. Med Biol 1984; 62 (2): 130-4
167. McCord JM. Superoxide dismutase: rationale for use in reperfusion injury and inflammation. J Free Radic Biol Med 1986; 2: 307-10
168. Greenwald RA. Superoxide dismutase and catalase as therapeutic agents for human diseases. Free Radic Biol Med 1990; 8: 201-9
169. Rangan U, Bulkley GB. Prospects for treatment of free radical-mediated tissue injury. Br Med Bull 1993; 49: 700-18
170. Torchilin V. Strategies and means for drug targeting. In: Muzykantov V, Torchilin V, editors. Biomedical aspects of drug targeting. Boston/London: Kluwer Academic Press, 2003: 3-26
171. Freeman BA, Young SL, Crapo JD. Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury. J Biol Chem 1983; 258: 12534-42
172. Beckman JS, Minor Jr RL, Freeman BA. Augmentation of antioxidant enzymes in vascular endothelium. J Free Radic Biol Med 1986; 2: 359-65
173. Suntres ZE, Shek PN. Treatment of LPS-induced tissue injury: role of liposomal antioxidants. Shock 1996; 6 Suppl. 1: S57-64
174. Suntres ZE, Shek PN. Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing alpha-tocopherol and glutathione. Bi-ohem Pharmacol 1996; 52 (10): 1515-20
175. Fan J, Shek PN, Suntres ZE, et al. Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery 2000; 128 (2): 332-8
176. Suntres ZE, Shek PN. Incorporation of alpha-tocopherol in liposomes promotes the retention of liposome-encapsulated glutathione in the rat lung. J Pharm Pharmacol 1994; 46 (1): 23-8
177. Shek PN, Suntres ZE, Brooks JI. Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery. J Drug Target 1994; 2 (5): 431-42
178. Nakae D, Yamamoto K, Yoshiji H, et al. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am J Pathol 1990; 136: 787-95
179. Corvo ML, Boerman OC, Oyen WJG, et al. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes: II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta 1999; 1419: 325-34
180. 2 toxicity. J Appl Physiol 1984; 57: 1674-81
181. Imaizumi S, Woolworth V, Fishman RA, et al. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 1990; 21: 1312-7
182. Stanimirovic DB, Markovic M, Micic DV, et al. Liposome-entrapped superoxide dismutase reduces ischemia/reperfusion 'oxidative stress' in gerbil brain. Neurochem Res 1994; 19 (12): 1473-8
183. Jadot G, Vaille A, Maldonado J, et al. Clinical pharmacokinetics and delivery of bovine superoxide dismutase. Clin Pharmacokinet 1995; 28 (1): 17-25
184. Aoki H, Fujita M, Sun C, et al. High-efficiency entrapment of superoxide dismutase into cationic liposomes containing synthetic aminoglycolipid. Chem Pharm Bull 1997; 45 (8): 1327-31
185. Baillet F, Housset M, Michelson AM, et al. Treatment of radiofibrosis with liposomal superoxide dismutase: preliminary results of 50 cases. Free Radic Res Commun 1986; 1 (6): 387-94
186. Delanian S, Baillet F, Huart J, et al. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase. Radiother Oncol 1994; 32: 12-20
187. Regnault C, Roch-Arveiller M, Tissot M, et al. Effect of encapsulation in liposomes on the anti-inflammatory properties of superoxide dismutase after oral administration. Clin Chim Acta 1995; 240: 117-27
188. Rocksen D, Ekstrand-Hammarstrom B, Johansson L, et al. Vitamin e reduces transendothelial migration of neutrophils and prevents lung injury in endotoxin induced airway inflammation. Am J Respir Cell Mol Biol 2003; 28 (2): 199-207
189. Muzykantov V. Biological barriers for drug targeting. In: Muzykantov V, Torchilin V, editors. Biomedical aspects of drug targeting. Boston/London: Kluwer Academic Press, 2003: 27-45
190. Abuchowski A, McCoy JR, Palczuk NC, et al. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 1977; 252: 3582-6
191. Veronese FM, Boccu E, Schiavon O, et al. Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene
192. Maksimenko AV, Petrov AD, Caliceti P, et al. The modification of Cu, Zn-superoxide dismutase by monomethoxypolyethylene glycol improves the indices of the experimental therapy of the ischemic myocardium in rats [in Russian]. Eksp Klin Farmakol 1993; 56 (5): 14-8
193. Viau AT, Abuchowski A, Greenspan S, et al. Safety evaluation of free radical scavengers PEG-catalase and PEG-superoxide dismutase. J Free Radic Biol Med 1986; 2: 283-8
194. Saifer MG, Somack R, Williams LD. Plasma clearance and immunologic properties of long-acting superoxide dismutase prepared using 35,000 to 120,000 dalton polyethylene glycol. Adv Exp Med Biol 1994; 366: 377-87
195. Beckman JS, Minor Jr RL, White CW, et al. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem 1988; 263: 6884-92
196. Holm BA, Hudak BB, Keicher L, et al. Mechanisms of H2O2-mediated injury to type II cell surfactant metabolism and protection with PEG-catalase. Am J Physiol Cell Physiol 1991; 261: C751-7
197. Walther FJ, Wade AB, Warburton D, et al. Augmentation of superoxide dismutase and catalase activity in alveolar type II cells. Am J Respir Cell Mol Biol 1991; 4: 364-8
198. McKinney JS, Willoughby KA, Liang S, et al. Stretch-induced injury of cultured neuronal, glial, and endothelial cells: effect of polyethylene glycol-conjugated superoxide dismutase. Stroke 1996; 27 (5): 934-40
199. Thomson PD, Till GO, Woolliscroft JO, et al. Superoxide dismutase prevents lipid peroxidation in burned patients. Burns 1990; 16: 406-8
200. Muizelaar JP, Marmarou A, Young HF, et al. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J Neurosurg 1993; 78: 375-82
201. Karlsson K, Sandstrom J, Edlund A, et al. Pharmacokinetics of extracellular-superoxide dismutase in the vascular system. Free Radic Biol Med 1993; 14: 185-90
202. Sandstrom J, Nilsson P, Karlsson K, et al. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem 1994; 269: 19163-6
203. Inoue M, Ebashi I, Watanabe N, et al. Synthesis of a superoxide dismutase derivative that circulates bound to albumin and accumulates in tissues whose pH is decreased. Biochemistry 1989; 28: 6619-24
204. Watanabe N, Inoue M, Morino Y. Inhibition of postischemic reperfusion arrhythmias by an SOD derivative that circulates bound to albumin with prolonged in vivo half-life. Biochem Pharmacol 1989; 38 (20): 3477-83
205. Inoue M, Watanabe N, Morino Y, et al. Inhibition of oxygen toxicity by targeting superoxide dismutase to endothelial cell surface. FEBS Lett 1990; 269: 89-92
206. Kawamoto S, Inoue M, Tashiro S, et al. Inhibition of ischemia and reflow-induced liver injury by an SOD derivative that circulates bound to albumin. Arch Biochem Biophys 1990; 277: 160-5
207. Takeda Y, Hashimoto H, Kosaka F, et al. Albumin-binding superoxide dismutase with a prolonged half-life reduces reperfusion brain injury. Am J Physiol Heart Circ Physiol 1993; 264: H1708-15
208. Igarashi R, Hoshino J, Ochiai A, et al. Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity. J Pharmacol Exp Ther 1994; 271: 1672-7
209. Yunoki M, Kawauchi M, Ukita N, et al. Effects of lecithinized superoxide dismutase on traumatic brain injury in rats. J Neurotrauma 1997; 14: 739-46
210. Yunoki M, Kawauchi M, Ukita N, et al. Effects of lecithinized SOD on sequential change in SOD activity after cerebral contusion in rats. Acta Neurochir Suppl 1998; 71: 142-5
211. Nakauchi K, Ikata T, Katoh S, et al. Effects of lecithinized superoxide dismutase on rat spinal cord injury. J Neurotrauma 1996; 13 (10): 573-82
212. Muzykantov VR. Targeting of superoxide dismutase and catalase to vascular endothelium. J Control Release 2001; 71 (1): 1-21
213. Fu J, Fiegel J, Krauland E, et al. New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 2002; 23 (22): 4425-33
214. Abu-Dahab R, Schafer UF, Lehr CM. Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion. Eur J Pharm Sci 2001; 14 (1): 37-46
215. Ochiai J, Takano H, Ichikawa H, et al. A novel water-soluble vitamin E derivative, 2-(alpha-D-glucopyranosyl)methyl-2,5,7,8-tetramethylchroman-6-ol, protects against acute lung injury and mortality in endotoxemic rats. Shock 2002; 18 (6): 580-4
216. Cheng W, Fu YX, Porres JM, et al. Selenium-dependent cellular glutathione peroxidase protects mice against a pro-oxidant-induced oxidation of NADPH, NADH, lipids, and protein. FASEB J 1999; 13 (11): 1467-75
217. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236 (6): 814-22
218. Metnitz PG, Bartens C, Fischer M, et al. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999; 25 (2): 180-5
219. Gadek JE, DeMichelle SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition ARDS group. Crit Care Med 1999; 27 (8): 1409-20
220. Hybertson BM, Leff JA, Beehler CJ, et al. Effect of vitamin E deficiency and supercritical fluid aerosolized vitamin E supplementation on interleukin-1-induced oxidative lung injury in rats. Free Radic Biol Med 1995; 18 (3): 537-42
221. Ward JA, Roberts RJ. Vitamin E inhibition of the effects of hyperoxia on the pulmonary surfactant system of the newborn rabbit. Pediatr Res 1984; 18 (4): 329-34
222. Wagner FM, Weber AT, Ploetze K, et al. Do vitamins C and E attenuate the effects of reactive oxygen species during pulmonary reperfusion and thereby prevent injury? Ann Thorac Surg 2002; 74 (3): 811-7
223. Bone HG, Sakurai H, Schenarts PJ, et al. Effects of manganese superoxide dismutase, when given after inhalation injury has been established. Crit Care Med 2002; 30: 856-60
224. Taylor CG, McCutchon TL, Boermans HJ, et al. Comparison of Zn and vitamin E for protection against hyperoxia-induced lung damage. Free Radic Biol Med 1997; 22 (3): 543-50
225. North LN, Mathias MM, Schatte CL. Effect of dietary vitamin E or selenium on prostaglandin dehydrogenase in hyperoxic rat lung. Aviat Space Environ Med 1984; 55: 617-9
226. Walther FJ, Nunez FL, David-Cu R, et al. Mitigation of pulmonary oxygen toxicity in rats by intratracheal instillation of polyethylene glycol-conjugated antioxidant enzymes. Pediatr Res 1993; 33 (4 Pt 1): 332-5
227. Folz RJ, Abushamaa AM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 1999; 103: 1055-66
228. Ahmed MN, Suliman HB, Folz RJ, et al. Extracellular superoxide dismutase protects lung development in hyperoxia-exposed newborn mice. Am J Respir Crit Care Med 2003; 167: 400-5
229. Hasselmark L, Malmgren R, Zetterstrom O, et al. Selenium supplementation in intrinsic asthma. Allergy 1993; 48 (1): 30-6
230. Jeong DW, Yoo MH, Kim TS, et al. Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-kappa B activation. J Biol Chem 2002; 277 (20): 17871-6
231. Romieu I, Meneses F, Ramirez M, et al. Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone. Am J Respir Crit Care Med 1998; 158 (1): 226-32
232. Grievink L, Jansen S, Veer P, et al. Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements. Occup Environ Med 1998; 55: 13-7
233. Chang LY, Crapo JD. Inhibition of airway inflammation and hyperreactivity by an antioxidant mimetic. Free Radic Biol Med 2002; 33 (3): 379-86
234. Trenga CA, Koenig JQ, Williams PV. Dietary antioxidants and ozone-induced bronchial hyperresponsiveness in adults with asthma. Arch Environ Health 2001; 56 (3): 242-9
235. Assa'ad AH, Ballard ET, Sebastian KD, et al. Effect of superoxide dismutase on a rabbit model of chronic allergic asthma. Ann Allergy Asthma Immunol 1998; 80: 215-24
236. Holick CN, Michaud DS, Stolzenberg-Solomon R, et al. Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol 2002; 156: 536-47
237. Arab L, Steck-Scott S, Fleishauer AT. Lycopene and the lung. Exp Biol Med (Maywood) 2002; 227: 894-9
238. Panda K, Chattopadhyay R, Chattopadhyay D, et al. Cigarette smoke-induced protein oxidation and proteolysis is exclusively caused by its tar phase: prevention by vitamin C. Toxicol Lett 2001; 123: 21-32
239. Welch RW, Turley E, Sweetmanm SF, et al. Dietary antioxidant supplementation and DNA damage in smokers and nonsmokers. Nutr Cancer 1999; 34 (2): 167-72
240. Suntres ZE, Shek PN. Prophylaxis against lipopolysaccharide-induced acute lung injury by alpha-tocopherol liposomes. Crit Care Med 1998; 26 (4): 723-9
241. Steinhorn RH, Albert G, Swartz DD, et al. Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. Am J Respir Crit Care Med 2001; 164 (5): 834-9
242. Bowler RP, Arcaroli J, Crapo JD, et al. Extracellular superoxide dismutase attenuates lung injury after hemorrhage. Am J Respir Crit Care Med 2001; 164: 290-4
243. Suliman HB, Ryan LK, Bishop L, et al. Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. Am J Physiol Lung Cell Mol Physiol 2001; 280: L69-78
244. Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 2001; 23 (2): 268-87
245. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the third national health and nutrition examination survey (NHANES III). Am J Epidemiol 2000; 151 (10): 975-81
246. Berger TM, Frei B, Rifai N, et al. Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to pro-longed hyperoxia: a pilot study. Pediatr Res 1998; 43 (6): 719-26
247. Davis JM, Richter SE, Biswas S, et al. Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase. J Perinatol 2000 20 (4): 213-6
248. Oury TD, Thakker K, Menache M, et al. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. Am J Respir Cell Mol Biol 2001; 25 (2): 164-9
249. Venkatesan N, Punithavathi V, Chandrakasan G. Curcumin protects bleomycin-induced lung injury in rats [published erratum appears in Life Sci 1998; 62 (19): PL295]. Life Sci 1997; 61 (6): PL51-8
250. Ward W, Molteni A, Tsao C, et al. Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 1990; 19: 1405-9
251. Ward WF, Molteni A, Tsao CH. Radiation induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor Cl242817. Radiat Res 1989; 117: 342-50
252. Nguyen L, Ward WF, Ts'ao CH, et al. Captopril inhibits proliferation of human lung fibroblasts in culture: a potential antifibrotic mechanism. Proc Soc Exp Biol Med 1994; 204: 80-4
253. Travis EL, Newman RA, Helbing SJ. WR 2721 modification of type II cell and endothelial cell function in mouse lung after single doses of radiation. Int J Radiat Oncol Biol Phys 1987; 13: 1355-9
254. Travis EL, Parkins CS, Holmes SJ, et al. WR-2721 protection of pneumonitis and fibrosis in mouse lung after single doses of x-rays. Int J Radiat Oncol Biol Phys 1984; 13: 1355-9
255. Vujaskovic Z, Feng QF, Rabbani ZN, et al. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity. Exp Lung Res 2002; 28 (7): 577-90
256. Epperly M, Bray J, Kraeger S, et al. Prevention of late effects of radiation lung damage by MnSOD gene therapy. Gene Ther 1998; 5: 196-208
257. Epperly MW, Epstein CJ, Travis EL, et al. Decreased pulmonary radiation resistance of manganese superoxide dismutase (MnSOD)-deficient mice is corrected by human manganese superoxide dismutase-plasmid/liposome (SOD2-PL) intratracheal gene therapy. Radiat Res 2000; 154: 365-74
258. Epperly MW, Sikora CA, DeFilippi SJ, et al. Pulmonary irradiation-induced expression of VCAM-I and ICAM-I is decreased by manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) gene therapy. Biol Blood Marrow Transplant 2002; 8: 175-87
259. Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol. Br J Radiol 1998; 71 (848): 892-4
260. Thresiamma KC, George J, Kuttan R. Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol 1996; 34 (9): 845-7
261. Redlich CA, Rockwell S, Chung JS, et al. Vitamin A inhibits radiation-induced pneumonitis in rats. J Nutr 1998; 128: 1661-4
262. Blumenthal RD, Lew W, Reising A, et al. Anti-oxidant vitamins reduce normal tissue toxicity induced by radio-immunotherapy. Int J Cancer 2000; 86: 276-80
263. Kelly FJ. Use of antioxidants in the prevention and treatment of disease. J Int Fed Clin Chem 1998; 10 (1): 21-3
264. Schwenke DC, Behr SR. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Circ Res 1998; 83: 366-77
265. Morton LW, Caccetta R, Puddey IB, et al. Chemistry and biological effects of dietary phenolic compounds: relevance to cardiovascular disease. Clin Exp Pharmacol Physiol 2000; 27 (3): 152-9
266. Pandya DP. Oxidant injury and antioxidant prevention: role of dietary antioxidants, minerals, and drugs in the management of coronary heart disease (Part II). Compr Ther 2002; 28 (1): 62-73
267. Marchioli R, Schweiger C, Levantesi G, et al. Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids 2001; 36 Suppl.: 53-63
268. Menotti A. Diet, cholesterol and coronary heart disease: a perspective. Acta Cardiol 1999; 54 (3): 169-72
269. Constans J, Seigneur M, Blann AD, et al. Effect of the anti-oxidants selenium and beta-carotene on HIV-related endothelium dysfunction. Thromb Haemost 1998; 80: 1015-7
270. Factor VM, Laskowska D, Insen MR, et al. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc Natl Acad Sci U S A 2000; 97 (5): 2196-201
271. Chen X, Mikhail SS, Ding YW, et al. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model in rats. Carcinogenesis 2000; 21 (8): 1531-6
272. La Veccia C, Braga C, Negri E, et al. Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer 1997; 73 (4): 525-30
273. Albanes D, Malila N, Taylor PR, et al. Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland). Cancer Causes Control 2000; 11 (3): 66-73
274. Erbas D, Soncul H, Turkozkan N, et al. Effect of selenium on ischemic and reperfusion injury in isolated guinea pig lungs. Gen Pharmacol 1995; 26 (8): 1669-72
275. Borek C, Ong A, Mason H, et al. Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. Proc Natl Acad Sci U S A 1986; 83 (5): 1490-4
276. Husain K, Sugendran K, Pant SC, et al. Biochemical and pathological changes in response to hyperoxia and protection by antioxidants in rats. Indian J Physiol Pharmacol 1992; 36 (2): 97-100
277. Marshall TA, Roberts RJ. In vitro and in vivo assessment of lipid peroxidation of infant nutrient preparations: effect of nutrition on oxygen toxicity. J Am Coll Nutr 1990; 9 (3): 190-9
278. Tangney CC, McCloskey KM, Aye PL. Effects of hyperoxia and diet on murine tissue levels of vitamin E and polyunsaturated fatty acids. Lipids 1988; 23 (7): 707-12
279. Bucher JR, Roberts RJ. Effects of alpha-tocopherol treatment on newborn rat lung development and injury in hyperoxia. Pediatr Pharmacol 1982; 2 (1): 1-9
280. Bertrand Y, Pincemail J, Hanique G, et al. Differences in tocopherol-lipid ratios in ARDS and non-ARDS patients. Intensive Care Med 1989; 15 (2): 87-93
281. Hybertson BM, Kitlowski RP, Jepson EK, et al. Supercritical fluid-aerosolized vitamin E pretreatment decreases leak in isolated oxidant-perfused rat lungs. J Appl Physiol 1998; 84 (1): 263-8
282. Chytil F. The lungs and vitamin A. Am J Physiol Lung Cell Mol Physiol 1992; 262 (5 Pt 1): L517-27
283. Belloni PN, Garvin L, Mao CP, et al. Effects of all-trans-retinoic acid in promoting alveolar repair. Chest 2000; 117 (5 Suppl. 1): 235S-41S
284. 2-induced inhibition of lung septation. Am J Physiol Lung Cell Mol Physiol 2002; 283 (5): L971-80
285. Lehman PA, Henderson Jr WR. Retinoid-induced inhibition of eosinophil LTC4 production. Prostaglandins 1990; 39 (5): 569-77
286. Massaro GD, Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol 1996; 270 (2 Pt 1): L305-10
287. Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997; 3 (6): 675-7
288. Massaro GD, Massaro D. Retinoic acid treatment partially rescues failed septation in rats and in mice. Am J Physiol Lung Cell Mol Physiol 2000; 278 (5): L955-60
289. Serrano-Mollar A, Closa D, Cortijo J, et al. P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine. Thorax 2002; 57 (7): 629-34
290. Weinbroum AA, Kluger Y, Ben Abraham R, et al. Lung preconditioning with N-acetyl-L-cysteine prevents reperfusion injury after liver no flow-reflow: a dose-response study. Transplantation 2001; 71 (2): 300-6
291. McClintock SD, Till GO, Smith MG, et al. Protection from half-mustard-gas-induced acute lung injury in the rat. J Appl Toxicol 2002; 22 (4): 257-62
292. Baboolal HA, Ichinose F, Ullrich R, et al. Reactive oxygen species scavengers attenuate endotoxin-induced impairment of hypoxic pulmonary vasoconstriction in mice. Anesthesiology 2002; 97 (5): 1227-33
293. Spapen H, Zhang H, Demanet C, et al. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest 1998; 113 (6): 1616-24
294. Fogarty A, Britton J. Nutritional issues and asthma. Curr Opin Pulm Med 2000; 6 (1): 86-9
295. Fogarty A, Britton J. The role of diet in the aetiology of asthma. Clin Exp Allergy 2000; 30 (5): 615-27
296. Kadrabova J, Mad'aric A, Kovacikova Z, et al. Selenium status is decreased in patients with intrinsic asthma. Biol Trace Elem Res 1996; 52 (3): 241-8
297. Misso NL, Powers KA, Gillon RL, et al. Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients. Clin Exp Allergy 1996; 26 (7): 838-47
298. Flatt A, Pearce N, Thomson CD, et al. Reduced selenium in asthmatic subjects in New Zealand. Thorax 1990; 45 (2): 95-9
299. Powell CV, Nash AA, Powers HJ, et al. Antioxidant status in asthma. Pediatr Pulmonol 1994; 18 (1): 34-8
300. Greene LS. Asthma and oxidant stress: nutritional, environmental, and genetic risk factors. J Am Coll Nutr 1995; 14 (4): 317-24
301. Soutar A, Seaton A, Brown K. Bronchial reactivity and dietary antioxidants. Thorax 1997; 52 (2): 166-70
302. Baker JC, Ayres JG. Diet and asthma. Respir Med 2000; 94 (10): 925-34
303. Picado C, Deulofeu R, Lleonart R, et al. Dietary micronutrients/ antioxidants and their relationship with bronchial asthma severity. Allergy 2001; 56 (1): 43-9
304. Villani F, Comazzi R, De Maria P, et al. Effect of dietary supplementation with polyunsaturated fatty acids on bronchial hyperreactivity in subjects with sea-sonal asthma. Respiration 1998; 65 (4): 265-9
305. Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, et al. Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants. Am J Respir Crit Care Med 2002; 166 (5): 703-9
306. Schunemann HJ, Freudenheim JL, Grant BJ. Epidemiologic evidence linking antioxidant vitamins to pulmonary function and airway obstruction. Epidemiol Rev 2001; 23 (2): 248-67
307. Horvathova M, Jahnova E, Gazdik F. Effect of selenium supplementation in asthmatic subjects on the expression of endothelial cell adhesion molecules in culture. Biol Trace Elem Res 1999; 69 (1): 15-26
308. Kennedy KA, Stoll BJ, Ehrenkranz RA, et al. Vitamin A to prevent bronchopulmo-nary dysplasia in very-low-birth-weight infants: has the dose been too low? The NICHD Neonatal Research Network. Early Hum Dev 1997; 49 (1): 19-31
309. Ehrenkranz RA, Ablow RC, Warshaw JB. Prevention of bronchopulmonary dysplasia with vitamin E administration during the acute stages of respiratory distress syndrome. J Pediatr 1979; 95 (5 Pt 2): 873-8
310. Ehrenkranz RA, Bonta BW, Ablow RC, et al. Amelioration of bronchopulmonary dysplasia after vitamin E administration: a preliminary report. N Engl J Med 1978; 299 (11): 564-9
311. Hale TW, Rais-Bahrami K, Montgomery DL, et al. Vitamin E toxicity in neonatal piglets. J Toxicol Clin Toxicol 1995; 33 (2): 123-30
312. Shenai JP, Kennedy KA, Chytil F, et al. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987; 111 (2): 269-77
313. Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low birth-weight infants. National Institute of Child Health and Human Develop-ment Neonatal Research Network. N Engl J Med 1999; 340 (25): 1962-8
314. Rush MG, Shenai JP, Parker RA, et al. Intramuscular versus enteral vitamin A supplementation in very low birth weight neonates. J Pediatr 1994; 125 (3): 458-62
315. Mayne ST. Beta-carotene, carotenoids, and disease prevention in humans. FASEB J 1996; 10 (7): 690-701
316. Virtamo J, Pietinen P, Huttunen JK, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003; 290 (4): 476-85
317. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET. J Natl Cancer Inst 1996; 88: 1550-8
318. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334 (18): 1150-5
319. Sies H, Stahl W. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 1995; 62 (6 Suppl.): 1315S-21S
320. Palace VP, Khaper N, Qin Q, et al. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med 1999; 26: 746-61
321. Schunemann HJ, McCann S, Grant BJ, et al. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol 2002; 155 (5): 463-71
322. Rautalahti M, Virtamo J, Haukka J, et al. The effect of alpha-tocopherol and betacarotene supplementation on COPD symptoms. Am J Respir Crit Care Med 1997; 156 (5): 1447-52
323. Stey C, Steurer J, Bachmann S, et al. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J 2000; 16 (2): 253-62
324. Bridgeman MM, Marsden M, Selby C, et al. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 1994; 49 (7): 670-5
325. Dorow P, Weiss T, Felix R, et al. Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction. Arzneimittel Forschung 1986; 36 (1): 131-3
326. Maayan C, Bar-Yishay E, Yaacobi T, et al. Immediate effect of various treatments on lung function in infants with cystic fibrosis. Respiration 1989; 55 (3): 144-51
327. Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003; 43: 233-60
328. Li J, Lee J-M, Johnson JA. Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells. J Biol Chem 2002; 277 (1): 388-94
329. De Long MJ, Prochaska HJ, Talalay P. Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols. Cancer Res 1985; 45 (2): 546-51
330. Forkert P-G, D'Costa D, El-Mestrah M. Expression and inducibility of alpha, pi and mu glutathione S-transferase protein and mRNA in murine lung. Am J Respir Cell Mol Biol 1999; 20: 143-52
331. Ma Q, Kinneer K. Chemoprotection by phenolic antioxidants: inhibition of tumor necrosis factor a´ induction in macrophages. J Biol Chem 2002; 277 (4): 2477-84
332. Ruby AJ, Kuttan G, Dinesh Babu K, et al. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995; 94: 79-83
333. Sreejayan, Rao MNA. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 1996; 49: 104-7
334. Piper JT, Singhal SS, Salameh MS, et al. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. J Biochem Cell Biol 1998; 30: 445-56
335. Motterlini R, Foresti R, Bassi R, et al. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000; 28 (8): 1303-12
336. Singh S, Aggarwal BB. Activation of transcription factor NF-kB is suppressed by curcumin (diferulolylmethane). J Biol Chem 1995; 270 (42): 24995-5000
337. Kang BY, Chung SW, Chung W-J, et al. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 1999; 384: 191-5
338. Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 1999; 39 (1): 41-7
339. Literat A, Su F, Norwicki M, et al. Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sci 2001; 70 (3): 253-67
340. Shoskes DA. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury. Transplantation 1998; 66: 147-52
341. Okada K, Wangpoengtrakul C, Tanaka T, et al. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr 2001; 131 (8): 2090-5
342. Lim GP, Chu T, Yang F, et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001; 21 (21): 8370-7
343. Venkatesan N. Pulmonary protective effects of curcumin against paraquat toxicity. Life Sci 2000; 66 (2): PL21-8
344. Kamal-Eldin A, Frank J, Razdan A, et al. Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids 2000; 35 (4): 427-35
345. Lampe JW, Peterson S. Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr 2002; 132 (10): 2991-4
346. Bradlow HL, Sepkovic DW. Diet and breast cancer. Ann N Y Acad Sci 2002; 963: 247-67
347. Chung EL. Chemoprevention of lung cancer by isothiocyanates and their conjugates in A/J mouse. Exp Lung Res 2001; 27 (3): 319-30
348. Kwak MK, Egner PA, Dolan PM, et al. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat Res 2001; 480-481: 305-15
349. Wattenberg LW, Bueding E. Inhibitory effects of 5-(2-pyrazinyl)-4-methyl- 1,2-dithiol-3-thione (oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard. Carcinogenesis 1986; 7: 1379-81
350. Wang R, Ibarra-Sunga O, Verlinski L, et al. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2000; 279 (1): L143-51
351. Fischer S, Maclean AA, Liu M, et al. Inhibition of angiotensin-converting enzyme by captopril: a novel approach to reduce ischemia-reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 2000; 120 (3): 573-80
352. Candan F, Alagozlu H. Captopril inhibits the pulmonary toxicity of paraquat in rats. Hum Exp Toxicol 2001; 20 (12): 637-41
353. Nici L, Calabresi P. Amifostine modulation of bleomycin-induced lung injury in rodents. Semin Oncol 1999; 26 (2 Suppl. 7): 28-33
354. Vujaskovic Z, Feng QF, Rabbani ZN, et al. Radioprotection of lungs by amifostine is associated with reduction in profibrogenic cytokine activity. Radiat Res 2002; 157 (6): 656-60
355. Nici L, Santos-Moore A, Kuhn C, et al. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine. Cancer 1998; 83 (9): 2008-14
356. Ortiz LA, Lasky JA, Safah H, et al. Exacerbation of bleomycin-induced lung injury in mice by amifostine. Am J Physiol Lung Cell Mol Physiol 1999; 277 (6 Pt 1): L1239-44
357. Izumi M, McDonald MC, Sharpe MA, et al. Superoxide dismutase mimetics with catalase activity reduce the organ injury in hemorrhagic shock. Shock 2002; 18 (3): 230-5
358. Gauuan PJ, Trova MP, Gregor-Boros L, et al. Superoxide dismutase mimetics: synthesis and structure-activity relationship study of MnTBAP analogues. Bioorg Med Chem 2002; 10 (9): 3013-21
359. Shimizu K, Rajapakse N, Horiguchi T, et al. Protective effect of a new nonpeptidyl mimetic of SOD, M40401, against focal cerebral ischemia in the rat. Brain Res 2003; 963 (1-2): 8-14
360. Vujaskovic Z, Batinic-Haberle I, Rabbani ZN, et al. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med 2002; 33 (6): 857-63
361. Schneider J, Friderichs E, Heintze K, et al. Effects of recombinant human superoxide dismutase on increased lung vascular permeability and respiratory disorder in endotoxemic rats. Circ Shock 1990; 30: 97-106
362. Koyama S, Kobayashi T, Kubo K, et al. Recombinant-human superoxide dismutase attenuates endotoxin-induced lung injury in awake sheep. Am Rev Respir Dis 1992; 145: 1404-9
363. Amari T, Kubo K, Kobayashi T, et al. Effects of recombinant human superoxide dismutase on tumor necrosis factor-induced lung injury in awake sheep. J Appl Physiol 1993; 74: 2641-8
364. Leff JA, Baer JW, Bodman ME, et al. Interleukin-1 induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in rats. Am J Physiol Lung Cell Mol Physiol 1994; 266: L2-8
365. McCormick JR, Harkin MM, Johnson KJ, et al. Suppression by superoxide dismutase of immune-complex-induced pulmonary alveolitis and dermal inflammation. Am J Pathol 1981; 102: 5-61
366. Parizada B, Werber MM, Nimrod A. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic Res Commun 1991; 15: 297-301
367. Nguyen TT, Cox JR, Herndon CS, et al. Effects of manganese superoxide dismutase on lung fluid balance after smoke inhalation. J Appl Physiol 1995; 78: 2161-8
368. Minamiya Y, Abo S, Kitamura M, et al. Endotoxin-induced hydrogen peroxide production in intact pulmonary circulation of rat. Am J Respir Crit Care Med 1995; 152: 348-54
369. Guice KS, Oldham KT, Caty M, et al. Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg 1989; 210: 740-7
370. Seekamp A, Lalonde C, Zhu DG, et al. Catalase prevents prostanoid release and lung lipid peroxidation after endotoxemia in sheep. J Appl Physiol 1988; 65: 1210-6
371. Milligan SA, Hoeffel JM, Goldstein IM, et al. Effect of catalase on endotoxin-induced acute lung injury in unanesthetized sheep. Am Rev Respir Dis 1988; 137: 420-8
372. Martin D, Korthuis RJ, Perry M, et al. Oxygen radical-mediated lung damage associated with alpha-naphthylthiourea. Acta Physiol Scand Suppl 1986; 548: 119-25
373. Kawada T, Kambara K, Arakawa M, et al. Pretreatment with catalase or dimethyl sulfoxide protects alloxan-induced acute lung edema in dogs. J Appl Physiol 1992; 73: 1326-33
374. Wright SE, Baron DA, Heffner JE. Intravenous eugenol causes hemorrhagic lung edema in rats: proposed oxidant mechanisms. J Lab Clin Med 1995; 125: 257-64
375. Doerschuk CM, Allard MF, Oyarzun MJ. Evaluation of reexpansion pulmonary edema following unilateral pneumothorax in rabbits and the effect of superoxide dismutase. Exp Lung Res 1990; 16: 355-67
376. Ogata H, Luo XX, Xu X. Comparison of effects of margarite extract and recombinant human superoxide dismutase on paraquat-induced superoxide anion radicals in rat lung. Circ Shock 1994; 43: 161-5
377. Mikawa K, Nishna K, Maekawa N, et al. Attenuation of hyperoxic lung injury in rabbits with superoxide dismutase: effects on inflammatory mediators. Acta Anaesthesiol Scand 1995; 39: 317-22
378. Shaffer SG, O'Neil DH, Thibeault DW. Administration of bovine superoxide dismutase fails to prevent chronic pulmonary sequelae of neonatal oxygen exposure in the rat. J Pediatr 1987; 110: 942-6
379. Flick MR, Milligan SA, Hoeffel JM, et al. Catalase prevents increased lung vascular permeability during air emboli in unanesthetized sheep. J Appl Physiol 1988; 64: 929-35
380. Breuer R, Tochner Z, Conner MW, et al. Superoxide dismutase inhibits radiation-induced lung injury in hamsters. Lung 1992; 170: 19-29
381. Walther FJ, Gidding CE, Kuipers IM, et al. Prevention of oxygen toxicity with superoxide dismutase and catalase in premature lambs. J Free Radic Biol Med 1986; 2: 289-93
382. Walther FJ, Kuipers IM, Pavlova Z, et al. Mitigation of pulmonary oxygen toxicity in premature lambs with intravenous antioxidants. Exp Lung Res 1990; 16: 177-89
383. White CW, Jackson JH, Abuchowski A, et al. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats. J Appl Physiol 1989; 66: 584-90
384. Mossman BT, Marsh JP, Hardwick D, et al. Approaches to prevention of asbestors-induced lung disease using polyethylene glycol (PEG)-conjugated catalase. J Free Radic Biol Med 1986; 2: 335-8
385. Olson NC, Grizzle MK, Anderson DL. Effect of polyethylene glycol-superoxide dismutase and catalase on endotoxemia in pigs. J Appl Physiol 1987; 63: 1526-32
386. Suzuki Y, Tanigaki T, Heimer D, et al. Polyethylene glycol-conjugated superoxide dismutase attenuates septic lung injury in guinea pigs. Am Rev Respir Dis 1992; 145: 388-93
387. Jackson RM, Veal CF, Beckman JS, et al. Polyethylene glycol-conjugated superoxide dismutase in unilateral lung injury due to re-expansion (re-oxygenation). Am J Med Sci 1990; 300: 22-8
388. Mossman BT, Marsh JP, Sesko A, et al. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 1990; 141: 1266-71
389. Turrens JF, Crapo JD, Freeman BA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 1984; 73: 87-95
390. Freeman BA, Turrens JF, Mirza Z, et al. Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase. Fed Proc 1985; 44: 2591-5
391. Miyahara T, Shibamoto T, Wang H-G, et al. Lecithinized superoxide dismutase attenuates phorbol myristate acetate-induced injury in isolated dog lung. Eur J Pharmacol 1998; 344: 231-9
392. Yamazaki C, Hoshino J, Hori Y, et al. Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice. Jpn J Pharmacol 1997; 75: 97-100
393. Takenaga M, Igarashi R, Ochiai A, et al. Effect of lecithinized superoxide dismutase (PC-SOD) on experimental pulmonary metastasis in mice. Free Radic Biol Med 1999; 26: 1117-25
394. Maunder RJ, Winn RK, Gleisner JM, et al. Effect of intravenous catalase on the pulmonary vascular response to endotoxemia in goats. J Appl Physiol 1988; 64: 697-704
395. Johnson A, Perlman MB, Blumenstock FA, et al. Superoxide dismutase prevents the thrombin-induced increase in lung vascular permeability: role of superoxide in mediating the alterations in lung fluid balance. Circ Res 1986; 59: 405-15
396. Muzykantov VR, Sakharov DV, Domogatsky SP, et al. Directed targeting of immunoerythrocytes provides local protection of endothelial cells from damage by hydrogen peroxide. Am J Pathol 1987; 128 (2): 276-85
397. Sakharov DV, Muzykantov VR, Domogatsky SP, et al. Protection of cultured endothelial cells from hydrogen peroxide-induced injury by antibody-conjugated catalase. Biochim Biophys Acta 1987; 930 (2): 140-4
398. Inoue M, Sato E, Nishikawa M, et al. Targeting superoxide dismutase to critical sites of action. Methods Enzymol 2002; 349: 346-54
399. Muzykantov V, Sacharov D, Sinitsyn V, et al. Specific killing of human endothelial cells by antibody-conjugated glucose oxidase. Anal Biochem 1988; 169: 383-9
400. Erdos E. Angiotensin-converting enzyme and the changes of our concept through the years. Hypertension 1990; 16: 363-70
401. Muzykantov V, Atochina E, Kuo A, et al. Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme. Am J Physiol Lung Cell Mol Physiol 1996; 270: L704-13
402. Danilov S, Martynov A, Klibanov A, et al. Radioimmunoimaging of lung vessels: an approach using indium-111-labeled monoclonal antibody to ACE. J Nucl Med 1989; 30: 1686-9
403. Danilov SM, Muzykantov VR, Martynov AV, et al. Lung is a target organ for monoclonal antibody to ACE. Lab Invest 1991; 64: 118-24
404. Danilov S, Atochina E, Hiemish H, et al. Interaction of monoclonal antibody to angiotensin-converting enzyme (ACE) with antigen in vitro and in vitro and in vivo: antibody targeting to the lung induces ACE antigenic modulation. Int Immunol 1994; 6: 1153-60
405. Muzykantov VR, Danilov SM. Targeting of radiolabeled monoclonal antibody against ACE to the pulmonary endothelium. In: Torchilin V, editor. Targeted delivery of imaging agents. Boca Raton (FL): CRC Press, 1995: 465-85
406. Muzykantov V, Atochina E, Ischiropoulos H, et al. Immunotargeting of antioxidant enzymes to the pulmonary endothelium. Proc Natl Acad Sci U S A 1996; 93: 5213-8
407. Atochina E, Balyasnikova I, Danilov S, et al. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. Am J Physiol Lung Cell Mol Physiol 1998; 275: L806-17
408. Watanabe K, Lam G, Keresztes R, et al. Lipopolysaccharides decrease ACE activity expressed by cultured human endothelial cells. J Cell Physiol 1992; 120: 433-9
409. Atochina E, Hiemish H, Muzykantov V, et al. Systemic administration of PAF in rat reduces specific pulmonary uptake of circulating monoclonal antibody to ACE. Lung 1992; 170: 349-58
410. Zeb T, Piedboeuf B, Gamache M, et al. P-selectin is upregulated early in the course of hyperoxic lung injury in mice. Free Radic Biol Med 1996; 21 (4): 567-74
411. Morise Z, Ueda M, Kitajima M, et al. Reactive oxygen species and vascular cell adhesion molecule-1 in distant organ failure following bile duct obstruction in mice. Dig Dis Sci 2002; 47 (3): 607-13
412. Almenar-Queralt A, Duperray A, Miles L, et al. Apical topography and modulation of ICAM-1 expression on activated endothelium. Am J Pathol 1995; 147: 1278-88
413. Beck-Schimmer B, Schimmer R, Warner R, et al. Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 1997; 17: 344-52
414. Vaporciyan AA, Mulligan MS, Warren JS, et al. Up-regulation of lung vascular ICAM-1 in rats is complement dependent. J Immunol 1995; 155 (3): 1442-9
415. Panes J, Perry M, Anderson D, et al. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol Heart Circ Physiol 1995; 269: H1955-64
416. Eppihimer MJ, Russell J, Anderson DC, et al. Endothelial cell adhesion molecule expression in gene-targeted mice. Am J Physiol 1997; 273: H1903-8
417. Danilov SM, Gavrilyuk VD, Franke FE, et al. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol 2001 (280): L1335-47
418. Murciano JC, Muro S, Koniaris L, et al. ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface. Blood 2003 May 15; 101 (10): 3977-84
419. Muro S, Wiewrodt R, Thomas A, et al. A novel endocytic pathway induced by clustering of endothelial ICAM-1 or PECAM-1. J Cell Sci 2003 Apr 15; 116 (Pt 8): 1599-609
420. Eppihimer MJ, Wolitzky B, Anderson DC, et al. Heterogeneity of expression of E and P-selectins in vivo. Circ Res 1996; 79: 560-9
421. Keelan ET, Licence ST, Peters AM, et al. Characterization of E-selectin expression in vivo with use of a radiolabeled monoclonal antibody. Am J Physiol 1994; 266: H278-90
422. Newman PJ. The biology of PECAM-1. J Clin Invest 1997; 99: 3-7
423. Muzykantov VR, Christofidou-Solomidou M, Balyasnikova I, et al. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci U S A 1999; 96 (5): 2379-84
424. 2 and endothelial oxidative stress. Am J Physiol Lung Cell Mol Physiol 1999; 277 (2 Pt 1): L271-81
425. Sherpereel A, Wiewrodt R, Christofidou-Solomidou M, et al. Intracellular immunotargeting of active reporter enzyme to endothelium in vivo [abstract]. Am J Respir Crit Care Med 2000; 161: A132
426. Christofidou-Solomidou M, Pietra GG, Solomides CC, et al. Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol 2000; 278 (4): L794-805
427. Li S, Tan Y, Viroonchatapan E, et al. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol 2000; 278: L504-11
428. Christofidou-Solomidou M, Scherpereel A, Wiewrodt R, et al. PECAM-1-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. Am J Physiol Lung Cell Mol Physiol 2003; 285: L283-92
429. Vaporiciyan AA, Delisser HM, Yan HC, et al. Platelet-endothelial cell adhesion molecule-1 (PECAM-1) is involved in neutrophil recruitment in vivo. Science 1993; 262: 1580-2
430. Kavanaugh A, Davis L, Jain R, et al. A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 monoclonal antibody in early rheumatoid arthritis. J Rheumatol 1996; 23: 1338-44
431. Rosenfeld W, Evans H, Jhaveri R, et al. Safety and plasma concentrations of bovine superoxide dismutase administered to human premature infants. Dev Phamacol Ther 1982; 5: 151-61
432. Rosenfeld W, Evans H, Concepcion L, et al. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 1984; 105: 781-5
433. Rosenfeld WN, Davis JM, Parton L, et al. Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1996; 97 (6 Pt 1): 811-7
434. Nelson SK, Gao B, Bose S, et al. A novel heparin-binding, human chimeric, superoxide dismutase improves myocardial preservation and protects from ischemia-reperfusion injury. J Heart Lung Transplant 2002; 21 (12): 1296-303
435. Tsao C, Greene P, Odlind B, et al. Pharmacokinetics of recombinant human superoxide dismutase in healthy volunteers. Clin Pharmacol Ther 1991; 50: 713-20
436. Uematsu T, Nagashima S, Umemura K, et al. Pharmacokinetics and safety of intravenous recombinant human superoxide dismutase (NK341) in healthy subjects. Int J Clin Pharmacol Ther 1994; 32: 638-41
437. Edwards DA, Ben-Jebria A, Langer R. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol 1998; 84: 379-85
438. Adjei A, Gupta P. Pulmonary delivery of therapeutic peptides and proteins. J Control Release 1994; 29: 361-73
439. Wall DA. Pulmonary absorption of peptides and proteins. Drug Deliv 1995; 2: 1-20
440. Gannon DE, He XM, Ward PA, et al. Time-dependent inhibition of oxygen radical induced lung injury. Inflammation 1990; 14: 509-22
441. Day BJ, Evans KS, Kang BH, et al. Immunolocalization of inhaled recombinant human manganese superoxide dismutase reveals a prolonged retention in lung surface lining fluids. Inhal Toxicol 1995; 7: 1109-20
442. Sahgal N, Davis JM, Robbins C, et al. Localization and activity of recombinant human CuZn superoxide dismutase after intratracheal administration. Am J Physiol Lung Cell Mol Physiol 1996; 271: L230-5
443. Das S, Horowitz S, Robbins CG, et al. Intracellular uptake of recombinant superoxide dismutase after intratracheal administration. Am J Physiol Lung Cell Mol Physiol 1998; 18: L673-7
444. ++ superoxide dismutase. Chest 1993; 104 (3): 811-5
445. Welty-Wolf KE, Simonson SG, Huang Y-CT, et al. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates: II. Morphometric analysis. J Appl Physiol 1997; 83: 559-68
446. Langenback EG, Davis JM, Robbins C, et al. Improved pulmonary distribution of recombinant human Cu/Zn superoxide dismutase, using a modified ultrasonic nebulizer. Pediatr Pulm 1999; 27 (2): 124-9
447. Crapo JD, DeLong DM, Sjostrom K, et al. The failure of aerosolized superoxide dismutase to modify pulmonary oxygen toxicity. Am Rev Respir Dis 1977; 115: 1027-33
448. Gordon T, Milligan SA, Levin J, et al. Apparent effect of catalase on airway edema in guinea pigs: role of endotoxin contamination. Am Rev Respir Dis 1987; 135: 854-9
449. Davis JM, Rosenfeld WN, Sanders RJ, et al. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol 1993; 74: 2234-41
450. Robbins CG, Horowitz S, Merritt TA, et al. Recombinant human superoxide dismutase reduces lung injury caused by inhaled nitric oxide and hyperoxia. Am J Physiol Lung Cell Mol Physiol 1997; 272 (5 Pt 1): L903-7
451. Simonson SG, Welty-Wolf KE, Huang Y-CT, et al. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates: I. Physiology and biochemistry. J Appl Physiol 1997; 83 (2): 550-8
452. Nakamura T, Ogawa Y. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury induced by the intratracheal instillation of endotoxin in piglets. Biol Neonate 2001; 80 (2): 163-8
453. Tang G, White JE, Gordon RJ, et al. Polyethylene glycol-conjugated superoxide dismutase protects rats against oxygen toxicity. J Appl Physiol 1993; 74: 1425-31
454. Thibeault DW, Rezaiekhaligh M, Mabry S. Lung antioxidant enzymes and cardiopulmonary responses in young rats exposed to hyperoxia and treated intra-tracheally with PEG catalase and superoxide dismutase. Exp Lung Res 1993; 19: 137-51
455. 2 injury. J Appl Physiol 1987; 63: 359-67
456. Tanswell AK, Olson DM, Freeman BA. Liposome-mediated augmentation of antioxidant defenses in fetal rat pneumocytes. Am J Physiol Lung Cell Mol Physiol 1990; 258: L165-72
457. Padmanabhan RV, Gudapaty R, Liener IE, et al. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. Am Rev Respir Dis 1985; 132: 164-7
458. Tanswell AK, Freeman BA. Liposome-entrapped antioxidant enzymes prevent lethal O2 toxicity in the newborn rat. J Appl Physiol 1987; 63: 347-52
459. Thibeault DW, Rezaiekhaligh M, Mabry S, et al. Prevention of chronic pulmonary oxygen toxicity in young rats with liposome-encapsulated catalase administered intratracheally. Pediatr Pulm 1991; 11: 318-27
460. Baker RR, Czopf L, Jilling T, et al. Quantitation of alveolar distribution of liposome-entrapped antioxidant enzymes. Am J Physiol Lung Cell Mol Physiol 1992; 263: L585-94
461. Barnard ML, Baker RR, Matalon S. Mitigation of oxidant injury to lung microvasculature by intratracheal instillation of antioxidant enzymes. Am J Physiol Lung Cell Mol Physiol 1993; 265: L340-5
462. Ledwozyw A. Protective effect of liposome-entrapped superoxide dismutase and catalase on bleomycin-induced lung injury in rats: II. Phospholipids of the lung surfactant. Acta Physiol Hung 1991; 78: 157-62
463. Davis JM, Rosenfeld WN, Koo MC, et al. Pharmacologic interactions of exogenous lung surfactant and recombinant human CuZn superoxide dismutase. Pediatr Res 1994; 35: 37-40
464. Nieves-Cruz B, Rivera A, Cifuentes J, et al. Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue. Am J Physiol Lung Cell Mol Physiol 1996; 270: L659-67
465. Walther FJ, David-Cu R, Supnet MC, et al. Uptake of antioxidants in surfactant liposomes by cultured alveolar type II cells is enhanced by SP-A. Am J Physiol Lung Cell Mol Physiol 1993; 265: L330-9
466. Briscoe P, Caniggia I, Graves A, et al. Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. Am J Physiol Lung Cell Mol Physiol 1995; 268: L374-80
467. Harrison J, Shi XL, Wang LY, et al. Novel delivery of antioxidant enzyme catalase to alveolar macrophages by Fc receptor-mediated endocytosis. Pharmacol Res 1994; 11: 1110-4
468. Rojanasakul Y, Shi XG, Deshpande D, et al. Protection against oxidative injury and permeability alteration in cultured alveolar epithelium by transferrin-catalase conjugate. Biochim Biophys Acta 1996; 1315: 21-8
469. Davis JM, Rosenfeld WN, Richter SE, et al. Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premture neonates with respiratory distress syndrome. Pediatrics 1997; 100 (1): 24-30
470. Wyde PR, Moore DK, Pimentel DM, et al. Recombinant superoxide dismutase administered by aerosol inhibits respiratory syncytial virus infection in cotton rats. Antiviral Res 1996; 31: 173-84
471. Davis JM. A role in the prevention of chronic lung disease. Biol Neonate 1998; 74: 29-34
472. Erzurum SC, Lemarchand P, Rosenfeld MA, et al. Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucleic Acids Res 1993; 21: 1607-12
473. Danel C, Erzurum SC, Prayssac P, et al. Gene therapy for oxidant injury-treated diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum Gene Ther 1998; 9: 1487-96
474. Engelhardt JF. Redox-mediated gene therapies for environmental injury: approaches and concepts. Antioxid Redox Signal 1999; 1: 5-27
475. Trubetskoy VS, Torchilin VP, Kennel SJ, et al. Use of N-terminal modified poly (L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. Bioconjug Chem 1992; 3: 323-7
476. David GL, Romieu I, Sienra-Monge JJ, et al. Nicotinamide adenine dinucleotide (phosphate) reduced: quinone oxidoreductase and glutathione s-transferase M1 polymorphisms and childhood asthma. Am J Respir Crit Care Med 2003; 168 (10): 1199-204